ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JAMES M FENTON | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| RALPH NEAS | — |
Pharmacy PHA
FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R.3839 - Drug Shortage Prevention Act of 2012 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 S.1734 - Generating Antibiotic Incentives Now Act of 2011 S.2295 - Patient Safety and Generic Labeling Improvement Act S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JAMES M FENTON | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| RALPH NEAS | — |
Copyright/Patent/Trademark CPT
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3497 - MODDERN Cures Act of 2011 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.27 Preserve Access to Affordable Generics Act S.373 Fair Prescription Drug Competition Act S.1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JAMES M FENTON | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| RALPH NEAS | — |
Medicare/Medicaid MMM
FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R.3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011 S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JAMES M FENTON | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| RALPH NEAS | — |
Budget/Appropriations BUD
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JAMES M FENTON | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| RALPH NEAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.